The Multiple Sclerosis Center
At the Multiple Sclerosis Center, we provide comprehensive care for people with MS and related diseases through a coordinated, multidisciplinary approach. We offer the latest diagnostic and therapeutic services, and work toward maximizing function, improving quality of life, and increasing independence for each patient.
Led by David Hafler, MD, MSc, the MS Center provides the most current treatment protocols available for multiple sclerosis, including approved and novel investigational therapies. The Center collaborates with physician-scientists in Human Translational Immunology to engage in basic research and clinical trials to advance both the understanding of the disorder and continually improve treatment options.
The MS Center has numerous clinical trials in progress with highly experienced team members, including specially trained physicians and nurses. Center staff works closely with neuroradiologists and utilize state-of-the-art magnetic resonance imaging (MRI) for diagnostic purposes as well as to monitor disease progression and response to therapy.
The Center has particiapted in pivotal trials in many of the currently approved drugs for MS, including glatiramer acetate (Copaxone®), interferons including Avonex®, mitoxantrone (Novantrone®), and natalizumab (Tysabri®).
To schedule an appointment or to speak to one of our specialists,
please call (203) 287-6100.